替莫唑胺治疗胶质母细胞瘤的耐药性产生机制研究进展

doi:10.19586/j.2095-2341.2021.0022

生物技术进展 ›› 2021, Vol. 11 ›› Issue (6): 705-710.DOI: 10.19586/j.2095-2341.2021.0022

替莫唑胺治疗胶质母细胞瘤的耐药性产生机制研究进展

姚婷婷(), 刘梦昱(), 赵鹏翔, 王惠, 仪杨, 谢飞, YAO Mawulikplimi Adzavon

北京工业大学环境与生命学部，北京 100124

收稿日期:2021-02-25 接受日期:2021-06-02 出版日期:2021-11-25 发布日期:2021-11-26
通讯作者: 刘梦昱
作者简介:姚婷婷 E-mail：1533031633@qq.com；
基金资助:
北京市博士后科研活动经费(2020-22-004)

Research Progress of Temozolomide in the Mechanism of Drug Resistance in Glioblastoma

Tingting YAO(), Mengyu LIU(), Pengxiang ZHAO, Hui WANG, Yang YI, Fei XIE, Mawulikplimi Adzavon YAO

Department of Environment and Life Science，Beijing University of Technology，Beijing 100124，China

Received:2021-02-25 Accepted:2021-06-02 Online:2021-11-25 Published:2021-11-26
Contact: Mengyu LIU

摘要/Abstract

摘要：

胶质母细胞瘤作为胶质瘤中恶性程度最高的原发性脑部肿瘤，具有治愈率低、复发率高、呈浸润性生长等特点，在不使用化疗药物的情况下，患者中位生存期仅为12.1个月。胶质母细胞瘤患者的标准治疗方法以手术切除为主，放化疗为辅，其中替莫唑胺（temozolomide，TMZ）作为一种新型的口服烷化剂，是目前用于胶质瘤化学治疗的一线药物。但经过替莫唑胺治疗后，患者中位生存期仅提高了2个月，主要原因为胶质母细胞瘤可对TMZ产生耐药性。胶质母细胞瘤对TMZ产生的耐药机制主要为DNA修复机制，其包括了O⁶?甲基鸟嘌呤DNA甲基转移酶（O⁶?methyl guanine DNA methyltransferase，MGMT）对药物作用位点进行的直接修复、错配修复（mismatch repair，MMR）及碱基切除修复（base excision repair，BER），这些修复机制可修复TMZ引起的DNA损伤，从而降低肿瘤细胞对TMZ敏感性。通过对近年来胶质母细胞瘤的TMZ耐药机制的研究进展进行介绍，旨在为发展新的治疗手段提供理论基础。

关键词: 胶质瘤, 替莫唑胺, DNA修复机制

Abstract:

Glioblastoma is the most malignant primary brain tumor in glioma， which has the characteristics of low cure rate， high recurrence rate and invasive growth. Without the use of chemotherapy drugs， the median survival time of patients is only 12.1 months. The standard treatment for patients with glioblastoma is surgical resection supplemented by chemoradiotherapy. Among them， temozolomide （TMZ） as a new oral alkylating agent， is the first?line drug in the current chemotherapy of glioma. However， median survival improved by only 2 months after temozolomide treatment， mainly because glioblastomas can develop resistance to TMZ. Glioblastoma on TMZ resistance mechanism is mainly DNA repair mechanisms， it includes O⁶?methyl guanine DNA methyltransferase （MGMT） of sites for the action of the drug directly repair， mismatch repair （MMR） and base excision repair （BER）， these repair mechanisms can repair DNA damage cause by TMZ， thereby reducing tumor cell sensitivity to TMZ. The research progress on the mechanism of TMZ drug resistance of glioblastoma in recent years was reviewed， in order to provide a theoretical basis for the development of new therapeutic methods.

Key words: glioma, temozolomide, DNA repair mechanism

中图分类号:

R739

姚婷婷, 刘梦昱, 赵鹏翔, 王惠, 仪杨, 谢飞, YAO Mawulikplimi Adzavon. 替莫唑胺治疗胶质母细胞瘤的耐药性产生机制研究进展[J]. 生物技术进展, 2021, 11(6): 705-710.

Tingting YAO, Mengyu LIU, Pengxiang ZHAO, Hui WANG, Yang YI, Fei XIE, Mawulikplimi Adzavon YAO. Research Progress of Temozolomide in the Mechanism of Drug Resistance in Glioblastoma[J]. Current Biotechnology, 2021, 11(6): 705-710.

参考文献 36

1	SANAI N, ALVAREZ‑BUYLLA A, BERGER M S. Neural stem cells and the origin of gliomas[J]. N. Engl. J. Med., 2005, 353(8): 811-822.
2	SCHWARTZBAUM J A, FISHER J L, ALDAPE K D, et al.. Epidemiology and molecular pathology of glioma[J]. Nat. Clin. Pract. Neurol., 2006, 2(9): 494-503.
3	CLOUGHESY T F, CAVENEE W K, MISCHEL P S. Glioblastoma: from molecular pathology to targeted treatment[J]. Annu. Rev. Pathol., 2014, 9(9): 1-25.
4	WEN P Y, WELLER M, LEE E Q, et al.. Glioblastoma in adults: a society for neuro-oncology (SNO) and european society of neuro-oncology (EANO) consensus review on current management and future directions[J]. Neuro. Oncol., 2020, 22(8): 1073-1113.
5	LOUIS D N, OHGAKI H, WIESTLER O D, et al.. The 2007 WHO classification of tumours of the central nervous system[J]. Acta. Neuropathol., 2007, 114(2): 97-109.
6	NEWLANDS E S, STEVENS M F, WEDGE S R, et al.. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials[J]. Cancer Treat. Rev., 1997, 23(1): 35-61.
7	ARORA A, SOMASUNDARAM K. Glioblastoma vs temozolomide: can the red queen race be won?[J]. Cancer Biol. Ther., 2019, 20(8): 1-8.
8	CHRISTMANN M, KAINA B. Epigenetic regulation of DNA repair genes and implications for tumor therapy[J]. Mutat. Res. Rev. Mutat. Res., 2017, 780: 15-28.
9	SRIVENUGOPAL K S, YUAN X H, FRIEDMAN H S, et al.. Ubiquitination-dependent proteolysis of O⁶-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O⁶-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea[J]. Biochemistry, 1996, 35(4): 1328-1334.
10	XU-WELLIVER M, Pegg A E. Degradation of the alkylated form of the DNA repair protein, O⁶-alkylguanine-DNA alkyltransferase[J]. Carcinogenesis, 2002, 23(5): 823-830.
11	LIM A, LI B F. The nuclear targeting and nuclear retention properties of a human DNA repair protein O⁶-methylguanine-DNA methyltransferase are both required for its nuclear localization: the possible implications[J]. Embo. J., 1996, 15(15): 4050-4060.
12	MARGISON G P, POVEY A C, KAINA B, et al.. Variability and regulation of O⁶-alkylguanine-DNA alkyltransferase[J]. Carcinogenesis, 2003, 24(4): 625-635.
13	KAINA B, CHRISTMANN M, NAUMANN S, et al.. MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents[J]. DNA Repair, 2007, 6(8): 1079-1099.
14	WICKSTR M M, DYBERG C, MILOSEVIC J, et al.. Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance [J/OL]. Nat. Commun., 2015, 6: 8904[2021-09-30]. .
15	GROMBACHER T, KAINA B. Constitutive expression and inducibility of O⁶-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in rat liver cells exhibiting different status of differentiation[J]. Biochim. Biophys. Acta, 1995, 1270(1): 63-72.
16	BOLDOGH I, RAMANA C V, CHEN Z, et al. Regulation of expression of the DNA repair gene O⁶-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling[J]. Cancer Res., 1998, 58(17):3950-3956.
17	WARREN K E, GURURANGAN S, GEYER J R, et al.. A phase II study of O⁶-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a pediatric brain tumor consortium study[J]. J. Neurooncol., 2012, 106(3): 643-649.
18	ROOS W P, BATISTA L F, NAUMANN S C, et al.. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O⁶-methylguanine[J]. Oncogene, 2007, 26(2): 186-197.
19	BARVAUX V A, LORIGAN P, RANSON M, et al.. Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O⁶-alkylguanine-DNA alkyltransferase[J]. Mol. Cancer Ther., 2004, 3(10): 1215-1220.
20	HERMISSON M, KLUMPP A, WICK W, et al.. O⁶-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells[J]. J. Neurochem., 2006, 96(3): 766-776.
21	WILSON D M, BARSKY D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA[J]. Mutat. Res., 2001, 485(4): 283-307.
22	CHAKRAVARTI D, IBEANU G C, TANO K, et al. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase[J]. J. Biol. Chem., 1991, 266(24): 15710-15715.
23	ENGELWARD B P, WEEDA G, WYATT M D, et al.. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase[J]. Proc. Natl. Acad. Sci. USA, 1997, 94(24): 13087-13092.
24	THANASUPAWAT T, NATARAJAN S, ROMMEL A,, et al.. Dovitinib enhances temozolomide efficacy in glioblastoma cells[J]. Mol. Oncol., 2017, 11(8): 1078-1098.
25	GUPTA S K, KIZILBASH S H, CARLSON B L, et al.. Delineation of MGMT hypermethylation as a biomarker for veliparib-mediated temozolomide-sensitizing therapy of glioblastoma[J/OL]. J. Natl. Cancer. Inst., 2015, 108(5): djv369[2021-09-30]. .
26	DANTZER F, DE LA RUBIA G, MÉNISSIER-DE M J, et al.. Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1[J]. Biochemistry, 2000, 39(25): 7559-7569.
27	CALDECOTT K W, AOUFOUCHI S, JOHNSON P, et al.. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro[J]. Nucl. Acids Res., 1996, 24(22): 4387-4394.
28	PRASAD R, LAVRIK O I, KIM S J, et al.. DNA polymerase β-mediated long patch base excision repair poly(ADP-ribose) polymerase-1 stimulates strand displacement dna synthesis[J]. J. Biol. Chem., 2001, 276(35): 32411-32414.
29	DIANOVA I I, SLEETH K M, LALLINSONet al S.. XRCC1-DNA polymerase interaction is required for efficient base excision repair[J]. Nucl. Acids Res., 2004, 32(8): 2550-2555.
30	PARSONS J L, DIANOVA I I, ALLINSON S L, et al.. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts[J]. FEBS J., 2010, 272(8):2012-2021.
31	SARKARIA J N, KITANGE G J, JAMES C D, et al.. Mechanisms of chemoresistance to alkylating agents in malignant glioma[J]. Clin. Cancer Res., 2008, 14(10): 2900-2908.
32	MCFALINE-FIGUEROA J L, BRAUN C J, STANCIU M, et al.. Minor changes in expression of the mismatch repair protein msh2 exert a major impact on glioblastoma response to temozolomide[J]. Cancer Res., 2015, 75(15): 3127-3138.
33	STRUVE N, BINDER Z A, STEAD L F, et al. EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma[J]. Oncogene, 2020, 39(15): 3041-3055.
34	STRUVE N, BINDER Z A, STEAD L F, et al.. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs[J]. Cell, 1994, 77(4): 491-502.
35	刘晨,安晓霞,张凡,等.肿瘤干细胞相关基因ABCB1、ABCG2表达与宫颈上皮恶变及发展关系的研究[J].现代妇产科进展,2012(04):294-297.
36	MARIS J, HOGARTY M, BAGATELL R, et al.. Neuroblastoma[J]. Lancet, 2007, 369(9579): 2106-2120.

[1]	汪超甲,王辉,胡钧涛,胡胜利,张宇强,成于思,雷尚国. CRISPR/Cas9敲除pyk2基因对人脑胶质瘤细胞增殖、迁移及侵袭能力的影响[J]. 生物技术进展, 2017, 7(4): 338-344.
[2]	张晶晶,王永峰,王国成,杨海龙,范立君. 替莫唑胺局部缓释制剂的研究进展[J]. 生物技术进展, 2014, 4(4): 263-267.

替莫唑胺治疗胶质母细胞瘤的耐药性产生机制研究进展

Research Progress of Temozolomide in the Mechanism of Drug Resistance in Glioblastoma

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 2

编辑推荐

Metrics

本文评价